Adicet Bio, Inc.

ACET
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001720580

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Apr 13, 20265:20 PM ETFeb 18 – Feb 20, 2026RA Capital Healthcare Fund LP and 3 others10% OwnerPPurchaseCommon Stock+223.6K$7.1734+$1.6M1.18M+23.3%SEC
Apr 9, 20265:38 PM ETApr 7 – Apr 8, 2026ORBIMED ADVISORS LLC and 7 others10% OwnerSSaleCommon Stock−104.66K$6.4481−$674.85K0−100.0%SEC
Oct 10, 20258:06 PM ETOct 8, 2025ORBIMED ADVISORS LLC and 7 others10% OwnerPPurchaseCommon Stock+5M$1.00+$5M4.49MNew positionSEC
Jun 7, 2024Jun 5, 2024Kauffman MichaelDirectorSSaleCommon Stock−5.9K$1.43−$8.44K5.9K−50.0%SEC
Jan 26, 20247:14 PM ETJan 25, 2024ORBIMED ADVISORS LLC and 7 othersDirector, 10% OwnerPPurchaseCommon Stock+3.13M$2.40+$7.5M1.26MNew positionSEC
Jan 26, 2024Jan 25, 2024GORDON CARL LDirector, 10% OwnerPPurchaseCommon Stock+3.13M$2.40+$7.5M1.26MNew positionSEC
Oct 2, 2023Sep 28, 2023Schor ChenPresident & CEOSSaleCommon Stock−5.5K$1.42−$7.81K37.97K−12.7%SEC
Oct 2, 2023Sep 28, 2023Schor ChenPresident & CEOPPurchaseCommon Stock+5.5K$1.42+$7.81K182.47K+3.1%SEC
Oct 2, 2023Sep 29, 2023Schor ChenPresident & CEOSSaleCommon Stock−5.5K$1.36−$7.48K176.97K−3.0%SEC
Oct 2, 2023Oct 2, 2023Schor ChenPresident & CEOPPurchaseCommon Stock+5.5K$1.33+$7.32K43.47K+14.5%SEC
Jun 30, 2023Jun 30, 2023DUBIN STEVEDirectorPPurchaseCommon Stock+5K$2.40+$12K10.9K+84.7%SEC
Jun 29, 20234:46 PM ETJun 27, 2023ORBIMED ADVISORS LLC and 8 othersDirector, 10% OwnerPPurchaseCommon Stock+875K$2.09+$1.83M748.05KNew positionSEC
Jun 29, 2023Jun 27, 2023GORDON CARL LDirector, 10% OwnerPPurchaseCommon Stock+875K$2.09+$1.83M748.05KNew positionSEC
Feb 17, 2023Feb 15, 2023Healey DonChief Technology OfficerSSaleCommon Stock−4.53K$7.57−$34.31K66.57K−6.4%SEC
Feb 14, 2023Feb 10, 2023Healey DonChief Technology OfficerSSaleCommon Stock−10.47K$7.98−$83.53K71.1K−12.8%SEC
Nov 15, 2022Nov 10, 2022Aftab BlakeChief Scientific OfficerSSaleCommon Stock−6.97K$21.00−$146.31K28.21K−19.8%SEC
Nov 15, 2022Nov 10, 2022Schor ChenPresident & CEOSSaleCommon Stock−9.96K$21.03−$209.35K91.47K−9.8%SEC
Nov 15, 2022Nov 10, 2022Schor ChenPresident & CEOSSaleCommon Stock−30K$20.06−$601.8K53.42K−36.0%SEC
Nov 9, 2022Nov 7, 2022Schor ChenPresident & CEOSSaleCommon Stock−30K$19.05−$571.5K83.42K−26.4%SEC
Nov 4, 2022Nov 2 – Nov 3, 2022Schor ChenPresident & CEOSSaleCommon Stock−25.31K$18.0392−$456.63K113.42K−18.2%SEC
Oct 21, 2022Oct 19, 2022Aftab BlakeChief Scientific OfficerSSaleCommon Stock−8.07K$16.27−$131.25K35.18K−18.7%SEC
Oct 14, 2022Oct 12, 2022Aftab BlakeChief Scientific OfficerSSaleCommon Stock−1.65K$15.40−$25.35K51.18K−3.1%SEC
Sep 16, 2022Sep 14, 2022Schor ChenPresident & CEOSSaleCommon Stock−952$18.00−$17.14K138.74K−0.7%SEC
Sep 13, 20224:59 PM ETSep 9 – Sep 13, 2022Schor ChenPresident & CEOSSaleCommon Stock−78.41K$16.7987−$1.32M139.69K−36.0%SEC
Aug 5, 2022Aug 3, 2022Aftab BlakeChief Scientific OfficerSSaleCommon Stock−6.97K$18.00−$125.42K38.97K−15.2%SEC
Aug 3, 2022Aug 1, 2022Aftab BlakeChief Scientific OfficerSSaleCommon Stock−6.97K$16.64−$115.95K45.94K−13.2%SEC
Jul 7, 2022Jul 5, 2022Aftab BlakeChief Scientific OfficerSSaleCommon Stock−1.36K$14.50−$19.76K52.9K−2.5%SEC
Apr 5, 2022Apr 1 – Apr 4, 2022Galimi FrancescoSVP & Chief Medical OfficerSSaleCommon Stock−15.6K$21.00−$327.6K59.92K−20.7%SEC
Mar 11, 2022Mar 9, 2022Jakobovits AyaDirectorSSaleCommon Stock−4K$14.00−$56K356.35K−1.1%SEC
Feb 17, 2022Feb 16, 2022Jakobovits AyaDirectorSSaleCommon Stock−4K$14.83−$59.32K358.35K−1.1%SEC
Feb 14, 2022Jan 3 – Feb 9, 2022Jakobovits AyaDirectorSSaleCommon Stock−24K$16.5058−$396.14K360.35K−6.2%SEC
Dec 13, 2021AmendedDec 8, 2021Sinclair AndrewDirectorPPurchaseCommon Stock+500K$14.00+$7M2.12M+31.0%SEC